Patent Number: 8,791,077

Title: Method for treating hyperuricemia employing an SGLT2 inhibitor and composition containing same

Abstract: Methods are provided for treating hyperuricemia, employing an SGLT2 inhibitor alone, or in combination with a supply of carbohydrate, and/or in combination with an inhibitor of uric acid synthesis. Additionally, pharmaceutical compositions comprising an SGLT2 inhibitor with a supply of carbohydrate or an inhibitor of uric acid synthesis or a supply of carbohydrate and an inhibitor of uric acid synthesis are provided in the instant invention and are provided for use in the inventive methods.

Inventors: Leslie; Bruce Robert (Princeton, NJ)

Assignee: AstraZeneca AB

International Classification: C07H 7/04 (20060101)

Expiration Date: 7/29/12018